About: The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2
Creator	Yang, Xue Chen, Jie Yang, Zifeng Chen, Liping Cai, Lihua Zhou, Hongxia Chen, Qimin Deng, Zhenxuan Liao, Yuping Liao, Zhou Ma, Qinhai Qiu, Minshan Shen, Lihan Zheng, Qianwei Zhou, Jinchao
source	Elsevier; Medline; PMC
abstract	covid:07274c25c0f6b1cce065ef815fb293c21606a0bb#abstract
has issue date	2020-07-09(xsd:dateTime)
bibo:doi	10.1016/j.phrs.2020.105073
bibo:pmid	32653650
has license	no-cc
sha1sum (hex)	07274c25c0f6b1cce065ef815fb293c21606a0bb
schema:url	https://doi.org/10.1016/j.phrs.2020.105073
resource representing a document's title	The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2
has PubMed Central identifier	PMC7347326
has PubMed identifier	32653650
schema:publication	Pharmacol Res
resource representing a document's body	covid:07274c25c0f6b1cce065ef815fb293c21606a0bb#body_text
is schema:about of	named entity 'Disease' named entity '2019' named entity 'SARS-CoV-2' named entity 'lymphocyte count' named entity 'hypoxaemia' named entity 'adverse reactions' named entity 'COVID-19' named entity 'traditional Chinese medicine' named entity 'COVID-19' named entity 'HFNC' named entity 'critically ill patients' named entity 'dyspnea' named entity 'PaCO2' named entity 'epidemiological' named entity 'COVID' named entity 'systemic inflammatory response syndrome' named entity 'coronaviruses' named entity 'WBC' named entity 'oxygen therapy' named entity 'interferon-α' named entity 'study protocol' named entity 'CRP' named entity 'Guangdong Province' named entity 'ICU' named entity 'PSI' named entity 'placebo' named entity 'COVID' named entity '5.5' named entity 'coronary heart disease' named entity 'blood stasis' named entity 'Severe Acute Respiratory Syndrome Coronavirus 2' named entity 'canula' named entity 'global pandemic' named entity 'normal saline' named entity 'sepsis' named entity 'diabetes' named entity 'severe pneumonia' named entity 'Lopinavir/ritonavir' named entity 'biochemical' named entity 'hypertension' named entity 'pneumonia' named entity 'COVID' named entity 'Corona Virus Disease' named entity 'dyspepsia' named entity 'COVID-19' named entity 'virulent' named entity 'coronavirus' named entity 'PSI' named entity 'SARS-CoV-2' named entity 'mmHg' named entity 'partial pressure' named entity 'symptomatic treatment' named entity 'adverse reactions' named entity 'PSI' named entity 'lymphocyte count' named entity 'epidemiological' named entity 'SCAP' named entity 'mechanical ventilation' named entity 'immune function' named entity 'therapeutic drug' named entity 'hypertension' named entity 'MODS' named entity 'significant difference' named entity 'Dongguan' named entity 'rash' named entity 'bed rest' named entity 'SARS-CoV-2'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software